Marshall Wace
SABSW icon

Marshall Wace’s SAB Biotherapeutics Warrant SABSW Stock Holding History

Marshall Wace’s Portfolio SABSW Stock Details SABSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-247,576
Closed -$173K – 3355
2022
Q3 		$173K Sell
247,576
-37,424
-13% -$4.46K ﹤0.01% 3118
2022
Q2 		$413K Hold
285,000
– – ﹤0.01% 2883
2022
Q1 		$1.07M Hold
285,000
– – ﹤0.01% 2424
2021
Q4 		$2.23M Buy
+285,000
New +$523K ﹤0.01% 1976

Other funds holding SABSW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return